Trilogy Metals (TMQ) At $0.66 Forms Bottom, COMPUMED (CMPD) Shorts Increased By 0.24%

May 24, 2017 - By Kurt Siggers

Trilogy Metals Inc (TMQ) formed multiple bottom with $0.62 target or 6.00% below today’s $0.66 share price. Trilogy Metals Inc (TMQ) has $71.77 million valuation. The stock decreased 2.66% or $0.018 on May 23, reaching $0.662. About shares traded. Trilogy Metals Inc (NYSEMKT:TMQ) has risen 6.48% since May 24, 2016 and is uptrending. It has underperformed by 10.22% the S&P500.

COMPUMED INCORPORATED (OTCMKTS:CMPD) had an increase of 0.24% in short interest. CMPD’s SI was 126,000 shares in May as released by FINRA. Its up 0.24% from 125,700 shares previously. With 5,900 avg volume, 21 days are for COMPUMED INCORPORATED (OTCMKTS:CMPD)’s short sellers to cover CMPD’s short positions. The stock decreased 16.67% or $0.01 on May 23, reaching $0.05. About 30,000 shares traded or 476.81% up from the average. CompuMed, Inc. (OTCMKTS:CMPD) has 0.00% since May 24, 2016 and is . It has underperformed by 16.70% the S&P500.

Analysts await Trilogy Metals Inc (NYSEMKT:TMQ) to report earnings on July, 6.

CompuMed, Inc. provides enterprise telemedicine solutions. The company has market cap of $1.58 million. The Company’s telecardiology and teleradiology offerings provide direct access to the United States Board-Certified specialists through cloud technology and integrated medical devices. It currently has negative earnings. The Company’s solutions primarily support the diagnosis and treatment of various diseases, particularly cardiovascular disease and osteoporosis.